General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients...

Asthma deaths levels increase by a quarter in a decade

Asthma deaths levels increase by a quarter in a decade

July 26 2018 There were 1,320 deaths due to asthma in England and Wales in 2017, the highest...

NPA and Age UK ask for help on building polypharmacy dossier

NPA and Age UK ask for help on building polypharmacy dossier

July 25 2018 The National Pharmacy Association is asking its members for case studies on...

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

July 24 2018 New Health Secretary Matt Hancock has called for investment in primary care and...

NHS Digital seeks views on SCR with Additional Information

NHS Digital seeks views on SCR with Additional Information

July 24 2018 A survey to assess the benefits and/or disadvantages of health professionals...

  • General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    General practice pharmacist scheme evaluation indicates ‘improved capacity’ as the main benefit

    Tuesday, 31 July 2018 15:31
  • Asthma deaths levels increase by a quarter in a decade

    Asthma deaths levels increase by a quarter in a decade

    Thursday, 26 July 2018 15:08
  • NPA and Age UK ask for help on building polypharmacy dossier

    NPA and Age UK ask for help on building polypharmacy dossier

    Wednesday, 25 July 2018 13:46
  • Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Pharmacy bodies welcome Health Secretary’s pledge to invest in community pharmacy

    Tuesday, 24 July 2018 12:53
  • NHS Digital seeks views on SCR with Additional Information

    NHS Digital seeks views on SCR with Additional Information

    Tuesday, 24 July 2018 12:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a lloyds healthcare centre imageJune 12 2018

A LloydsPharmacy Healthcare Centre based in Scunthorpe has become the first pharmacy to provide a breast cancer treatment service providing Herceptin injections.

In a partnership with Northern Lincolnshire and Goole NHS Foundation Trust (NLaG), the clinic provides the service at a LloydsPharmacy branch in in the town, with a nurse administering the subcutaneous Herceptin (trastuzumab) injection. The service enables patients to receive their three-weekly Herceptin injections, administered by an oncology nurse, closer to their homes.

The service has the ability to deliver 1,200 treatments a year, and could save patients up to 14 hospital trips a year out of the total 17 treatments they receive. Suitable patients may be referred to the community pharmacy service following a discussion with a nurse on the ward at Scunthorpe hospital. All referrals to the clinic are reviewed by the patient’s oncologist.

The service follows on from the launch of a Xolair (omalizumab) injection immunology service for asthma patients at the same pharmacy, announced in April. Other services delivered under the Healthcare Centres’ concept include work with the Greater Manchester Cancer Vanguard to spot signs of cancer earlier, and a pharmacist-delivered osteoporosis injection service (denosumab) in the West Midlands.

Andy Burton, director of community services at Celesio UK, the parent company of LloydsPharmacy, said: “We want to make it easier and more convenient for patients to receive their treatment and free up busy hospitals to deal with more acute cases. 

“Patient appointments for their Herceptin treatment are no longer fraught with the stress of car parking and long waits, instead they have been replaced by a service with a dedicated nursing team delivered in a convenient community pharmacy.”

Further patient pathways are being reviewed “to enable other patients to benefit from this cutting-edge service,” he added.

Links:
LloydsPharmacy announcement            
Today’s Pharmacist coverage of omalizumab injection service    

Practice News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...